1 Min Read
Sept 15 (Reuters) - U.S. Food and Drug Administration:
* On Sept 14, U.S. FDA approved first generic version of Tamiflu for oral suspension, 6 mg (base)/ml by Nesher Pharmaceuticals USA LLC (Bengaluru Newsroom: +91 806 749 1136)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.